Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $78.00 in the prior trading day, Insmed Inc (NASDAQ: INSM) closed at $76.29, down -2.19%. In other words, the price has decreased by -$2.19 from its previous closing price. On the day, 2.41 million shares were traded. INSM stock price reached its highest trading level at $80.63 during the session, while it also had its lowest trading level at $75.57.
Ratios:
Our goal is to gain a better understanding of INSM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.99 and its Current Ratio is at 6.37. In the meantime, Its Debt-to-Equity ratio is 2.41 whereas as Long-Term Debt/Eq ratio is at 2.38.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on April 23, 2024, initiated with a Buy rating and assigned the stock a target price of $48.
On February 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $42.
On December 08, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $55.Wells Fargo initiated its Overweight rating on December 08, 2023, with a $55 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 30 ’25 when Schaeffer Orlov S Nicole bought 91,140 shares for $80.00 per share.
Flammer Martina M.D. sold 1,384 shares of INSM for $95,108 on Jan 14 ’25. The Chief Medical Officer now owns 100,165 shares after completing the transaction at $68.72 per share. On Jan 14 ’25, another insider, Adsett Roger, who serves as the Chief Operating Officer of the company, sold 1,457 shares for $68.72 each. As a result, the insider received 100,125 and left with 146,082 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSM now has a Market Capitalization of 13648510976 and an Enterprise Value of 13340497920. For the stock, the TTM Price-to-Sale (P/S) ratio is 39.80 while its Price-to-Book (P/B) ratio in mrq is 28.22. Its current Enterprise Value per Revenue stands at 38.898 whereas that against EBITDA is -19.193.
Stock Price History:
The Beta on a monthly basis for INSM is 1.12, which has changed by 1.7679205 over the last 52 weeks, in comparison to a change of 0.21794415 over the same period for the S&P500. Over the past 52 weeks, INSM has reached a high of $80.53, while it has fallen to a 52-week low of $21.92. The 50-Day Moving Average of the stock is 5.50%, while the 200-Day Moving Average is calculated to be 18.48%.
Shares Statistics:
The stock has traded on average 1.79M shares per day over the past 3-months and 1891660 shares per day over the last 10 days, according to various share statistics. A total of 178.85M shares are outstanding, with a floating share count of 174.62M. Insiders hold about 2.39% of the company’s shares, while institutions hold 106.04% stake in the company. Shares short for INSM as of 1736899200 were 15089466 with a Short Ratio of 8.45, compared to 1734048000 on 13010105. Therefore, it implies a Short% of Shares Outstanding of 15089466 and a Short% of Float of 8.540000000000001.
